Related Experiment Video
Updated: Mar 25, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
A model-based meta-analysis of sofosbuvir-based treatments in chronic hepatitis C patients
Alejandro Pérez-Pitarch1, Beatriz Guglieri-López2, Rafael Ferriols-Lisart1
1Pharmacy Department, University Clinical Hospital of Valencia, Avda. Blasco Ibañez 17, Valencia 46010, Spain; Pharmacy and Pharmaceutical Technology Department, University of Valencia, Valencia, Spain.
Abstract:
The objective of this study was to compare the efficacy of sofosbuvir-based treatments in patients with chronic hepatitis C virus (HCV) infection using a model-based meta-analysis (MBMA). A bibliographic search was performed to identify clinical trials involving sofosbuvir as a unique direct-acting antiviral (DAA) agent or together with daclatasvir, ledipasvir or simeprevir for the treatment of diagnosed HCV infection. The time course of the virological response (VR) was modelled to estimate the effect of treatment and the influence of population characteristics on the longitudinal efficacy profile. The model was validated and simulations of 10 different treatment schedules were performed. Data from 19 clinical trials were included in the analysis. According to the developed model, therapy with sofosbuvir+ledipasvir is the most effective therapy in all scenarios, but it does not differ greatly in terms of sustained VR with respect to other combinations of DAA treatments. In conclusion, this MBMA generates knowledge regarding hypothetical head-to-head trials that have not been conducted previously. Therapies with sofosbuvir+ledipasvir are probably the most effective sofosbuvir-based treatments.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Hepatitis
Subviral Agents
Cystic Fibrosis: Management
Sinus disease and chronic...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

